中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 35 Issue 8
Aug.  2019
Turn off MathJax
Article Contents

Research advances in the role of protective autophagy in regulating vasculogenic mimicry formation in malignancies such as cholangiocarcinoma

DOI: 10.3969/j.issn.1001-5256.2019.08.053
Research funding:

 

  • Received Date: 2019-03-09
  • Published Date: 2019-08-20
  • Cholangiocarcinoma is a primary malignant tumor derived from the epithelium of the intrahepatic and extrahepatic bile ducts, and vasculogenic mimicry induced by hypoxia and lack of nutrition is a key factor for malignant proliferation, recurrence, and metastasis of cholangiocarcinoma. Previous studies have shown that autophagy maintains cell nutrition metabolism under the condition of a lack of nutrition, and preliminary experiments have confirmed that autophagy was associated with VM in cholangiocarcinoma and there was high expression of PAT4 in cholangiocarcinoma cells; on the basis of these studies, it is pointed out that in cholangiocarcinoma, protective autophagy regulates VM formation by maintaining intracellular metabolic balance and cellular homeostasis. As a nutrient sensor in tumor microenvironment, PAT4 mediates protective autophagy via the PI3 K-Akt-m TORC1 signaling pathway to regulate VM formation. Histological, cellular molecular, and in vivo experiments have confirmed that autophagy regulates VM formation by maintaining cell metabolism, stem cell features, and extracellular matrix remodeling, which helps to investigate the signal mechanism for PAT4 mediating autophagy to regulate VM. It is suggested that autophagy is the source of energy and nutrition in cholangiocarcinoma cells under the condition of a lack of nutrition, and PAT4 is the trigger point for autophagy in regulating VM formation. These findings provide new thoughts for the metabolism of cholangiocarcinoma cells and lay a theoretical foundation for antiangiogenic drugs combined with autophagy inhibitors in the treatment of highly aggressive tumors.

     

  • loading
  • [1] MANIOTIS AJ, FOLBERG R, HESS A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro:Vasculogenic mimicry[J]. Am J Pathol, 1999, 155 (3) :739-752.
    [2] XIA Y, CAI XY, FAN JQ, et al. The role of sema4D in vasculogenic mimicry formation in non-small cell lung cancer and the underlying mechanisms[J]. Int J Cancer, 2019, 144 (9) :2227-2238.
    [3] ZHAO X, SUN B, LIU T, et al. Long noncoding RNA n339260promotes vasculogenic mimicry and cancer stem cell development in hepatocellular carcinoma[J]. Cancer Sci, 2018, 109 (10) :3197-3208.
    [4] SHEN Y, QUAN J, WANG M, et al. Tumor vasculogenic mimicry formation as an unfavorable prognostic indicator in patients with breast cancer[J]. Oncotarget, 2017, 8 (34) :56408-56416.
    [5] WILLIAMSON SC, METCALF RL, TRAPANI F, et al. Vasculogenic mimicry in small cell lung cancer[J]. Nat Commun, 2016, 7:13322.
    [6] CHENG Y, OU K, ZHU WT, et al. Role and mechanism of vasculogenic mimicry induced by CCL21-CCR7 in micrometastasis of hilar cholangiocarcinoma[J]. World Chin J Dig, 2014, 22 (22) :3274-3280. (in Chinese) 成雨, 欧琨, 朱文涛, 等. CCL21-CCR7诱导血管生成拟态形成在肝门部胆管癌微转移中的作用及机制[J].世界华人消化杂志, 2014, 22 (22) :3274-3280.
    [7] GALLUZZI L, BAEHRECKE EH, BALLABIO A, et al. Molecular definitions of autophagy and related processes[J]. EMBO J, 2017, 36 (13) :1811-1836.
    [8] QU X, SHENG J, SHEN L, et al. Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS[J]. PLo S One, 2017, 12 (3) :e0173712.
    [9] GREEN DR. To be or not to be? How selective autophagy and cell death govern cell fate[J]. Cell, 2014, 157 (1) :65-75.
    [10] LIU W, LV C, ZHANG B, et al. MicroRNA-27b functions as a new inhibitor of ovarian cancer-mediated vasculogenic mimicry through suppression of expression[J]. RNA, 2017, 23 (7) :1019-1027.
    [11] ZENG F, JU RJ, LIU L, et al. Application of functional vincristine plus dasatinib liposomes to deletion of vasculogenic mimicry channels in triple-negative breast cancer[J]. Oncotarget, 2015, 6 (34) :36625-36642.
    [12] IZAWA Y, KASHII-MAGARIBUCHI K, YOSHIDA K, et al.Stem-like human breast cancer cells initiate vasculogenic mimicry on matrigel[J]. Acta Histochem Cytoc, 2018, 51 (6) :173-183.
    [13] HAEFEN C, SIFRINGER M, MENK M. Ethanol enhances susceptibility to apoptotic cell death via down-regulation of autophagy-related proteins[J]. Alcohol Clin Exp Res, 2011, 35 (8) :1381-1391.
    [14] YANG J, ZHU DM, ZHOU XG, et al. HIF-2αpromotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter[J]. Oncotarget, 2017, 8 (29) :47801-47815.
    [15] LIU ZY. Role and molecular mechanism of ZEB1 in vasculogenic mimicry formation in colon cancer[D]. Tianjin:Tianjin Medical University, 2012. (in Chinese) 刘志勇. ZEB1在结肠癌血管生成拟态形成中的作用及分子机制探讨[D].天津:天津医科大学, 2012.
    [16] PUSHPAKUMAR SB, KUNDU S, METREVELI N, et al. Matrix metalloproteinase inhibition mitigates renovascular remodeling in salt-sensitive hypertension[J]. Physiol Rep, 2013, 1 (3) :e00063.
    [17] RUIZ A, ROCKFIELD S, TARAN N, et al. Effect of hydroxychloroquine and characterization of autophagy in a mouse model of endometriosis[J]. Cell Death Dis, 2016, 7:e2059.
    [18] ZHANG S, LI M, ZHANG D, et al. Hypoxia influences linearly patterned programmed cell necrosis and tumor blood supply patterns formation in melanoma[J]. Lab Invest, 2009, 89 (5) :575-586.
    [19] SHAO B, ZHAO X, LIU T, et al. LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma[J]. J Cell Mol Med, 2019, 23 (2) :1363-1374.
    [20] ZHANG J, DENG G, QIAO L, et al. Effect of galectin-3 on vasculogenic mimicry in esophageal cancer cells[J]. Oncol Lett, 2019, 17 (1) :719.
    [21] HAN C, SUN B, WANG W, et al. Overexpression of microtubule-associated protein-1 light chain 3 is associated with melanoma metastasis and vasculogenic mimicry[J]. Tohoku J Exp Med, 2011, 223 (4) :243-251.
    [22] DING YP, YANG XD, WU Y. Autophagy promotes the survival and development of tumors by participating in the formation of vasculogenic mimicry[J]. Oncol Rep, 2014, 31 (5) :2321-2327.
    [23] MIGUEL-ALIAGA I. Nerveless and gutsy:Intestinal nutrient sensing from invertebrates to humans[J]. Semin Cell Dev Biol, 2012, 23 (6) :614-620.
    [24] MATSTU T. Rab12 regulates m TORC1 activity and autophagy through controlling the degradation of amino-acid transporter PAT4[J]. EMBO Rep, 2013, 14 (5) :450-457.
    [25] FAN SJ, SNELL C, TURLEY H, et al. PAT4 levels control amino-acid sensitivity of rapamycin-resistant m TORC1 from the Golgi and affect clinical outcome in colorectal cancer[J]. Oncogene, 2016, 35 (23) :3004-3015.
    [26] YEH YH, HSIAO HF, YEH YC, et al. Inflammatory interferon activates HIF-1α-mediated epithelial-to-mesenchymal transition via PI3K/AKT/m TOR pathway[J]. J Exp Clin Canc Res, 2018, 37 (1) :70.
    [27] ZHU ZB, YE LS, ZHENG CX. The role of PI3K/Akt signaling pathway in cholangiocarcinoma[J/CD]. Chin J Hepat Surg:Electronic Edition, 2016, 5 (5) :330-333. (in Chinese) 朱泽斌, 叶林森, 郑朝旭. PI3K/Akt信号通路在胆管癌中的作用[J/CD].中华肝脏外科手术学电子杂志, 2016, 5 (5) :330-333.
    [28] LIU Z, WANG F, ZHOU ZW, et al. Alisertib induces G/M arrest, apoptosis, and autophagy via PI3K/Akt/m TOR-and p38 MAPK-mediated pathways in human glioblastoma cells[J]. Am J Transl Res, 2017, 9 (3) :845-873.
    [29] CHIABLAEM K, LIRDPRAPAMONGKOL K, KEERATICHAMROEN S, et al. Curcumin suppresses vasculogenic mimicry capacity of hepatocellular carcinoma cells through STAT3 and PI3K/AKT inhibition[J]. Anticancer Res, 2014, 34 (4) :1857-1864.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1088) PDF downloads(219) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return